Brain infusion trial offers hope for halting Huntington's progression
NCT ID NCT06826612
Summary
This early-stage study is testing a one-time experimental therapy called SPK-10001 for Huntington's disease. Doctors will infuse the therapy directly into specific areas of the brain. The main goals are to see if the treatment is safe and if it can slow the progression of the disease in 53 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUNTINGTON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beth Israel Deaconess Medical Center
RECRUITINGBoston, Massachusetts, 02215, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Ohio State University
RECRUITINGColumbus, Ohio, 43221, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Cincinnati/Cincinnati Children's Hospital
RECRUITINGCincinnati, Ohio, 45221, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19107, United States
-
University of Pittsburg
RECRUITINGPittsburgh, Pennsylvania, 15213, United States
Conditions
Explore the condition pages connected to this study.